Other Information
−Removed: During the three months ended September 30, 2025 , none of our directors or officers entered into new or amended written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5 - 1 (c).
+Added: During the three months ended December 31, 2025 , none of our directors or officers entered into new or amended written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5 - 1 (c).
Description of Exhibit
3 unchanged sentences
(incorporated by reference from Exhibit 3.1 to the Company's Current Report on Form 8-K filed May 10, 2019).
−Removed: Amended and Restated Credit Agreement, dated as of April 5, 2024, by and among the Company, the guarantors and lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the joint lead arrangers and joint bookrunners party thereto.
−Removed: Mesa Laboratories, Inc Amended and Restated 2021 Equity Incentive Plan.
−Removed: Form of Amendment to Executive Employment Agreements, by and between Mesa Laboratories, Inc.
−Removed: and each of Messrs.
−Removed: Owens, Sakys and Archbold.
+Added: Amended and Restated Credit Agreement, dated as of April 5, 2024, by and among the Company, the guarantors and lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the joint lead arrangers and joint bookrunners party thereto (incorporated by reference from Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed November 6, 2025.)
+Added: Mesa Laboratories, Inc Amended and Restated 2021 Equity Incentive Plan (incorporated by reference from Exhibit 10.2.3 to the Company's Quarterly Report on Form 10-Q filed November 6, 2025).
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
* Furnished herewith
−Removed: α Mesa Laboratories, Inc.
−Removed: has entered into an Executive Employment Agreement with each of Gary M.
−Removed: Owens, John V.
−Removed: Sakys and Brian Archbold.
−Removed: ** Indicates a management contract or compensatory plan, contract or arrangement, or an amendment thereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MESA LABORATORIES, INC.
−Removed: November 6, 2025
+Added: February 3, 2026
Chief Executive Officer
−Removed: November 6, 2025
+Added: February 3, 2026
Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.